Lead Chelating Activity [MoA]: Side Effects & Safety Data for 2 Drugs
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
Lead Chelating Activity [MoA] includes 2 drugs with a combined 179 adverse event reports in the FDA FAERS database. Compare their safety profiles, side effects, and outcomes below.
2
Drugs in Class
179
Combined Reports
All Lead Chelating Activity [MoA] Drugs Ranked by Reports
| Drug | Brand Name | Reports | Deaths | Hosp. | Death Rate |
|---|---|---|---|---|---|
| EDETATE | Edetate Calcium Disodium | 145 | 9 | 107 | 6.2% |
| SUCCIMER | NephroScan | 34 | 0 | 2 | N/A |
Common Side Effects in Lead Chelating Activity [MoA] Drugs
| Side Effect | Reports | Deaths |
|---|---|---|
| Condition aggravated | 122 | 8 |
| Drug ineffective | 93 | 7 |
| Musculoskeletal stiffness | 91 | 7 |
| Pain in extremity | 91 | 6 |
| Arthralgia | 90 | 6 |
| Gastrointestinal toxicity | 90 | 6 |
| Hepatotoxicity | 90 | 6 |
| Joint injury | 90 | 7 |
| Musculoskeletal pain | 90 | 6 |
| Neoplasm malignant | 90 | 6 |